A Study of LY03003 in Patients With Early-stage Parkinson's Disease
Status:
Completed
Trial end date:
2015-06-11
Target enrollment:
Participant gender:
Summary
This study is to characterize the pharmacokinetics and to evaluate the safety as well as
tolerability of LY03003 following multiple escalating intramuscular injections